These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17094465)

  • 21. Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids.
    He J; Luster TA; Thorpe PE
    Clin Cancer Res; 2007 Sep; 13(17):5211-8. PubMed ID: 17785577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy.
    Snell LM; Lin GH; McPherson AJ; Moraes TJ; Watts TH
    Immunol Rev; 2011 Nov; 244(1):197-217. PubMed ID: 22017440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 4-1BB-mediated immunotherapy of rheumatoid arthritis.
    Seo SK; Choi JH; Kim YH; Kang WJ; Park HY; Suh JH; Choi BK; Vinay DS; Kwon BS
    Nat Med; 2004 Oct; 10(10):1088-94. PubMed ID: 15448685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
    Lynch DH
    Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis.
    Sumi T; Ishida W; Mittler RS; Yagita H; Taguchi O; Fukushima A
    Int Arch Allergy Immunol; 2009; 148(4):305-10. PubMed ID: 19001790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway.
    Haga T; Suzuki J; Kosuge H; Ogawa M; Saiki H; Haraguchi G; Maejima Y; Isobe M; Uede T
    J Mol Cell Cardiol; 2009 May; 46(5):719-27. PubMed ID: 19233196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination immunotherapy with 4-1BB activation and PD-1 blockade enhances antitumor efficacy in a mouse model of subcutaneous tumor.
    Shindo Y; Yoshimura K; Kuramasu A; Watanabe Y; Ito H; Kondo T; Oga A; Ito H; Yoshino S; Hazama S; Tamada K; Yagita H; Oka M
    Anticancer Res; 2015 Jan; 35(1):129-36. PubMed ID: 25550543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy.
    Choi BK; Kim YH; Kang WJ; Lee SK; Kim KH; Shin SM; Yokoyama WM; Kim TY; Kwon BS
    Cancer Res; 2007 Sep; 67(18):8891-9. PubMed ID: 17875731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy.
    Sega EI; Lu Y; Ringor M; Leamon CP; Low PS
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):559-66. PubMed ID: 18411004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy.
    Sanchez-Paulete AR; Labiano S; Rodriguez-Ruiz ME; Azpilikueta A; Etxeberria I; Bolaños E; Lang V; Rodriguez M; Aznar MA; Jure-Kunkel M; Melero I
    Eur J Immunol; 2016 Mar; 46(3):513-22. PubMed ID: 26773716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity.
    Ko E; Luo W; Peng L; Wang X; Ferrone S
    Cancer Res; 2007 Aug; 67(16):7875-84. PubMed ID: 17699794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.
    Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I
    Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune response.
    Stagg J; Sharkey J; Pommey S; Young R; Takeda K; Yagita H; Johnstone RW; Smyth MJ
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16254-9. PubMed ID: 18838682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M; Phan TT; Searle PF
    Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting.
    Houtenbos I; Westers TM; Dijkhuis A; de Gruijl TD; Ossenkoppele GJ; van de Loosdrecht AA
    Clin Cancer Res; 2007 Jan; 13(1):307-15. PubMed ID: 17170077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NLCQ-1 (NSC 709257) in combination with radiation against human glioma U251 xenografts.
    Papadopoulou MV; Bloomer WD; Hollingshead MG
    Anticancer Res; 2005; 25(3B):1865-9. PubMed ID: 16158918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agonistic anti-4-1BB antibody promotes the expansion of natural regulatory T cells while maintaining Foxp3 expression.
    Zhang P; Gao F; Wang Q; Wang X; Zhu F; Ma C; Sun W; Zhang L
    Scand J Immunol; 2007 Oct; 66(4):435-40. PubMed ID: 17850588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiological effects of vascular endothelial growth factor receptor-2-blocking antibody plus fractionated radiotherapy on murine mammary tumors.
    Fenton BM; Paoni SF; Ding I
    Cancer Res; 2004 Aug; 64(16):5712-9. PubMed ID: 15313911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.